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1. Introduction  
Cardiovascular diseases (CVD) are one of the leading cause of mortality in both men and women 
in the world. According to a WHO report, about 55% of deaths in European women are related 
to CVD, including 23% caused by coronary artery disease (CAD) and 18% due to stroke. 
Conversely, in men, CVD is the cause of 43% of deaths, including CAD (21%) and stroke (11%). 
These statistics are alarming — in Europe, one woman dies of CVD every 6 minutes. 
In respect of above data is very important to perform randomized clinical trials with women 
treated for acute coronary syndromes (ACS). This operation was initiated relatively not long 
ago. In the past 40 years, the attention of cardiologists regarding the treatment of coronary 
artery disease (CAD) has been focused mainly on the group of male patients, markedly less 
on the female population.  
In the meantime, to the best of our knowledge, despite of apparent similarity of ACS clinical 
course in men and women, differences in the pathophysiological mechanisms, prevalence 
and profile of risk factors, angiographic changes, kind of treatment and prognosis are found.  
These observations are particularly important up against constantly rising cardiovascular 
morbidity and mortality among women.  
2. Comparison of clinical course in women and men treated from ACS 
2.1 Coronary risk factors in female and male 
Acute coronary syndromes in women are the real challenge for clinical and invasive 
cardiologists. The ACS diagnosis and therapy in female are more difficult than in male. It is 
connected with ACS women older age, major coronary risk factors number, differences in 
pathophysiology and clinical course and complication during procedures. The coronary risk 
factors in women and men are the same, but their influence on female, especially during 
menopause is different than in male. This effect results from female specific hormone 
constellation during menopausal period. Generally,  in ACS women population, the 
coronary risk factors are more often found than in ACS male group and this is the inverse 
phenomenon compared to population without myocardial infarction. 
In majority of currently ACS registries these observations were affirmed. According to data 
from Polish ACS Registry (26035 patients with ACS STEMI hospitalized between 2005-2006;  
8989 (34,5%) females) women were older than men by 7.7 years on average and this was 
statistically significant. In women, the well established risk factors  were significantly more 
www.intechopen.com
 Coronary Angiography – The Need for Improvement in Medical and Interventional Therapy  
 
82
prevalent than in men: hypertension: 67,0% vs 56,1%, diabetes: 28% vs 16,6%, obesity: 23,7% 
vs 13,4% (p<0,001 for all groups). Only the prevalence of hypercholesterolemia was similar 
in both sexes and smoking was less often in female.  
Analysis of Swedish registry: ACS-AMIS Plus Registry  evaluated over 20- thousands ACS 
population (28% female) hospitalized between 1997-2006 also showed older women age by 
7,5 years on average and more often presence of hypertension and diabetes in women.  
Similar observation can be run into worldwide registries.  
According to data from Chinese ACS Registry (CRACE) – 1301 ACS patients, 24,4% women 
treated from 2001 to 2004, female subjects were also significant older than male patients 
(67.23 years vs 61.80 years, P < 0.0001). The incidence of diabetes mellitus and hypertension 
in the female group was higher than in male group (30.8% vs 18.6%, p < 0.0001 and 66.4% vs 
56.8%, p = 0.001 respectively), conversely, the incidence of smoking was less in female group 
than men group (6,6% vs 66,2%, p<0,001). 
Longstanding observation of female and male population hospitalized from ACS in USA in 
years 1997-2006 demonstrated significantly frequent prevalence of hypertension, diabetes 
mellitus, heart failure and cerebrovascular diseases in women from all aging categories.  
Beside of greater number of risk factors in women than in men, stronger impact some of 
them to woman organism is again and again suspected. First of all, this finding affects 
smoking. The risk of acute coronary syndrome in smoking women is about six fold higher 
compared to no- smoking female, whereas in smoking men only three fold risk increase is 
observed. The cause of this effect is probably adverse influence nicotine for hormonal profile 
in women. It is proved that smoking women have lower estrogen level.  
The similar observation regard impact of diabetes for ACS risk in female. The prevalence of 
diabetes frequently correlates with acute coronary syndromes in women than in men.  
The next differences are connected with lipid profile. Stronger prognostic impact of higher 
LDL level in men is indicated, whereas in women the big importance of low HDL level is 
emphasized. Low HDL-C levels  in women have been shown to be a risk factor for CHD and 
premature atherosclerosis independent of serum LDL-C and triglyceride levels. In female 
with established coronary disease, low HDL-C levels may be a better predictor of 
subsequent coronary events than high levels of LDL-C. The Nurses’ Health Study estimates 
that a 17 mg/dL elevation in HDL-C reduces the risk of CHD development in 
postmenopausal women by approximately 40%. Generally, the risk of CHD decreases by 3% 
for every 1 mg/dL increase in HDL-C in women, but only by 2% in men. Similarly, the 
presence of diabetes tends to confer a more negative effect on HDL-C and triglycerides (TG) 
in diabetic women compared to men.  
Angiographic and ultrasound evidence demonstrate that low plasma levels of HDL-C are 
associated with major severity of CHD in females and males, as indicated by an increase in 
the number and extent of coronary vessel involvement. Furthermore, among men and 
women with angiographic evidence of CHD but with normal total cholesterol levels, 
patients with HDL-C levels <35 mg/dL had significantly more cardiovascular events than 
those with higher levels. Then, the correlation between lipid profile in female and male are 
complicated. The further observations are necessary to confirm these interdependences. 
2.2 Clinical characteristic of acute coronary syndrome process in women and men 
Studies compared ACS clinical symptoms in women and men demonstrate different results. 
According to part of them myocardial infarction clinical course is similar in female and male. 
In contrast, other observations convince of significant differences in ACS gender manifestation.  
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Myocardial infarction symptoms in men are usually typical: strong retrosternal pain with 
typical radiation, without reaction or with transient abating after nitroglycerin usage.  
Women with acute coronary syndrome more often complain for atypical disorders: back 
pain, neck pain, nausea or vomiting, dyspnea, palpitation or strong weakness. In women 
more often indolent myocardial infarction course was also affirmed.   
The interesting meta- analytic evaluation of ACS gender differences confirmed these 
observations.  Review of articles and dissertation from 1966 to 2007  demonstrated that 
above gender differences of moderate or larger magnitude were evident and women were 
more likely than men to report non-specific symptoms. For most symptoms, the magnitude 
of effects did not vary across different symptom-assessment strategies.  
Additionally, majority contemporary studies showed that ACS women were admitted to 
hospital later then ACS men and, this fact also suggests more often presence atypical 
complains in female.  
Data from Polish ACS Registry (over 20 thousands ACS women) demonstrated that women 
especially during the first 3 hours from symptom onset, presented to hospital significantly 
less often and that the delay of > 12 hours occurred more often in this patients.  
Likewise, Swedish ACS Registry showed that female patients came to hospital later then 
men- median difference 60 minut. The delay on admission with atypical ACS symptoms in 
women may cause worse effect of therapy.  
The five month analysis over 6 thousands group of consecutive patients presenting with 
ACS showed that patients with atypical presentation were significantly less likely to receive 
evidence-based therapy and coronary angiography and suffered worse in-hospital 
outcomes. After adjustment for confounders, the absence of typical chest pain was 
associated with higher mortality rate (odds ratio 2.0, 95% confidence intervals 1.29-2.75).  
On the other hand women even though presenting the typical ACS symptoms, often are 
treated worse than men. First of all, to this time, myocardial infarction is perceived as “male 
disease “. Female and doctors often ignore important disorders, in contrast, paradoxically, 
typical symptoms are the strongest ACS predictors in women. Chest pain has consistently 
been underestimated in women because of the disappointing results of evaluations of this 
symptom in the past.  
In women, more often than in men, despite the clinical and biochemical ACS characteristic, 
changes in coronary angiography aren’t found. In the CASS (Coronary Artery Surgery 
Study), 30% of women with typical angina and 64% with atypical angina had normal 
coronary angiograms, but this was observed in only 7% and 34% of men, respectively.  
Syndrome X, which was defined as symptoms and signs of myocardial ischemia in the presence 
normal coronary angiograms, predominates in women, but this syndrome may represent 
microvascular disease or endothelial dysfunction, which are more often observed in women.  
Recently, data from WISE (Women’s Ischemia Syndrome Evaluation) and WTH (Women 
Take Heart) studies demonstrated, that rates of cardiovascular events were highest for 
symptomatic women with nonobstructive coronary artery disease compared to 
symptomatic women with normal coronary arteries; on the other hand, symptomatic 
women with normal coronary arteries had almost three-fold higher rates of events when 
compared to asymptomatic women. These facts suggest that in women, as in men, chest 
pain compatible with angina deserves careful evaluation.   
The following observations of ACS clinical course in women demonstrate worse clinical 
presentation on admission. It is probably a consequence of older female age and more risk 
factors.  
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Analysis of contemporary European  and American ACS Registries confirm higher 
frequency of heart failure in Killip-Kimball class III-IV in female compared with male.  
Presumably atypical ACS symptoms, delay from onset pain to admission and worse clinical 
presentation on admission contribute to still emphasized less often women qualifications to 
invasive procedures. According to Polish ACS Registry primary PCI was performed in 
47,8% women and 57,4% men (p<0,001).  
In Swedish AMIS Plus Registry reperfusion strategy was used in 27,2% women and 36,6 % 
men (p<0,001).  
Data from in the American College of Cardiology–National Cardiovascular Data Registry also 
showed lower utilization rates of emergent PCI for women than for men across all ethnic subsets.  
The next problem, mentioned above, is specific coronary angiography changes in women 
presenting ACS. The reasons for more often presence of normal coronary arteries or non 
critical narrows in coronary artery angiography performed in ACS women are unclear. The 
mostly accepted conception is phenomenon of atherosclerotic plaque erosion with thrombus 
formed on apparently undamaged artery wall. These findings were obtained on the basis 
postmortem examinations patients died from ACS -  in 37% women the surface plaque 
damage without significant coronary artery injury was demonstrated.  
Other studies with widely intravascular technique (IVUS) usage showed in women without 
significant changes in coronary angiograms a presence of atherosclerotic process in ACS 
responsible arteries.  
Additionally, female and male unstable angina consecutive studies demonstrated 
qualitative and quantitative gender differences between morphology of atherosclerotic 
plaques. Women atherosclerotic plaques indicated lower optical density and less expressed 
calcification than men plaques.  
However, presently there are the disagreements in reports estimated atherosclerotic plaques 
morphology. The contemporary analysis of plaque components in 362 ACS patients (254 
men, 108 women) showed no differences between  female and male atherosclerotic plaques. 
In this study more often occurrence of diabetes and high hsCRP level  in ACS women than 
men was emphasized and with these factors more female plaques instability was related.  
These contradictions in studies, order to searching another reasons of specific coronary 
changes in women.  
The next conception posits the differences in plaque reaction for response to hormonal 
factors and thrombogenic stimulation.  
According to epidemiological data the protective role of endogenic estrogens in young 
women is widely known. It is directly connected with impact of these hormones to 
coagulation system.  
In young, premenopausal women the lower fibrinogen and VII coagulation factor’s level  
was affirmed. Women in each age with family premature coronary diseases review, 
demonstrate excessive platelet aggregation. Following the excessive thrombocytes 
aggregation in these patients the bigger number of fibrinogen molecules are indicated - 
perhaps invisible during coronary angiography atherosclerotic changes undergoing action 
of stronger prothrombic factors in some women.  
Moreover, in connection with higher prothrombic inclination, probably we can more often 
observe a distal microvessels embolisation effect  imperceptible during routine coronary 
angiography. Therefore, the differences in coronary angiography changes between female 
and male could be more complicated than earlier suspected.  
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3. Specific ACS coronary angiography changes in women during pregnancy 
and postpartum period 
3.1 Epidemiology of acute coronary syndromes during pregnancy and postpartum 
period 
Myocardial infarction in pregnant women is an extremely rare event. The frequency of ACS 
in this period is difficult to estimate. According to the scarce epidemiological studies, in the 
United States the incidence of AMI in pregnancy ranges from 2.81 to 6.22 cases per 100,000 
deliveries. No data are available for Europe or other countries. In addition, these studies do 
not differentiate between AMI with and without ST-segment elevation. 
Currently we can observe increased frequency of acute coronary syndromes during 
pregnancy or postpartum period. This effect is probably connected with old age of 
pregnant women, and, generally increasing morbidity of coronary diseases among young 
women.  
Presently, women at first more often give the time for professional career, holding off 
maternity for later years of life. In the meantime, the risk of complication during pregnancy 
significantly increased with aging – it is emphasized, that myocardial infarction during 
pregnancy usually occurs in pregnant women after 33 years old.  
The analysis of literature demonstrated, that in older pregnant, multiparas, more often the 
typical, atherosclerotic substrate of acute coronary syndrome was indicated. Majority of 
them have occurred in III pregnancy trimester.  
However, in younger mothers, primiparas, the ACS pathogenesis is often atypical with 
often occurrence’s during postpartum period.  
3.2 Hemodynamic, hormonal and biochemical transitions during pregnancy affecting 
to cardiovascular system 
Pregnancy isn’t termed as coronary risk factor, although in this period a lot of changes in 
circulatory system, hormonal and coagulation parameters transformations are 
demonstrated. During pregnancy the increase of ejection volume and acceleration of 
cardiac activity is indicated. Both changes cause growth of oxygen cardiac muscle 
demand. 
Additionally, the physiological anemia and decrease of systolic and diastolic pressure 
contribute for limitation in oxygen delivery to cardiac muscle’s cells.  
Moreover, increase of volume blood circulating and ejection fraction causes intensification 
of the shearing forces action for big arteries walls –these effects can provoke coronary 
arteries dissection.  
Hormonal changes during pregnancy relies on increased progesterone production leading 
of impairment vascular wall through losing of normal elastic fibers structure, reticuline 
fibers fragmentation and decrease of acid mucopolisacharides. These effects also aggravate 
the risk of arteries dissection. 
Changes in coagulation system during pregnancy are connected with increment of 
fibrinogen and factors VII, VIII, IX, X, XII and von Willebrand factor’s concentration. In 
result of increase concentration of inhibitors of plasminogen activator PAI-1 and PAI-2, the 
serum fibrinolytic activity is decreased. It caused hipercoagulation state, which worsening 
during delivery when the great of PAI- 1 amount is released from placenta.  
The essence above changes is often occurrence atypical ACS patophysiology during 
pregnancy and postpartum period.  
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3.3 Coronary angiography changes during acute coronary syndromes in pregnancy 
based on pathophysiological substrate 
According to current reports, the most often cause of acute coronary syndrome in pregnant 
women, similarly to overall population, is sudden atherosclerotic rupture. Atherosclerotic 
changes was indicated in 40% pregnant women, in majority ACS symptoms occurred in 
antepartum period (54%).  
According to mentioned above high ACS risk in older pregnant women, in these population 
the higher number of coronary risk factors is indicated.  
The myocardial infarction risk during pregnancy rises 2,4 fold in women with hypertension, 
4,9 fold in smoking and 6,9 fold in diabetics.  
Idiopathic coronary artery dissection rarely appeares in general population, whereas during 
pregnancy, the frequency of this effect may approximate even 27%. Usually it is observed in 
peripartum (50%) or postpartum (34%) period – in connection with described earlier changes in 
arteries walls construction and hemodynamic disorders. Some of authors suggest that coronary 
artery dissection in pregnant women is even more often, though the artery wall undergoes 
essential healing and if the coronary angiography is performed after acute ACS phase, the image 
of angiogram may be correct. Relatively often, the coronary dissection in these women is found 
in more than one artery. It suggests existence of generalized arteries pathology.  
Another possible pathophysiological cause of acute coronary syndrome in pregnant women 
is angiospasm. The recognition of coronary artery spasm as the reason of myocardial 
infarction is difficult, because the angiospasm may be transient with quick idiopathic return 
of normal coronary flow.  
In Roth’s analysis coronary spasm only in 2% women was documented and only during 
antepartum period. Nonetheless in 13 % these patients angiograms were normal, perhaps in 
part of them the angiospasm occurred before the procedure had been performed.  
Normal coronary angiogram occurrs in equal proportion during all pregnancy periods. The 
potential reason of acute coronary syndrome in women without significant angiographic 
changes beside of healing dissection or transient angiospasm may be thrombus or embolus, 
which were resolved.   
In 8% women the cause of myocardial infarction was exactly thrombus. It can be connected 
with mentioned above tend to hipercoagulation state. 
Angiography changes are usually localized in only one of coronary artery, extremely rarely 
we can find multivessel disease in pregnancy. The single case of multivessel atherosclerotic 
changes in 41- years old postpartum woman come from own observation. In the literature 
we can meet also single multivessel dissection description.   
3.4 Coronary interventions during pregnancy 
Currently, the most effective therapy of acute coronary syndrome’s is primary coronary 
intervention. This procedure during pregnancy  is connected with dangerous fetus exposure 
to radiation. It can cause genetic disorders, height inhibition, different malformations.  
Bithell and Stuart demonstrated that children exposed to radiation during fetal life are 
characterized major cancer development risk. The dose of radiation until 1 rad is considered 
as no dangerous for fetus. This doses is simultaneously enough to performed diagnostic and 
therapeutic procedures.  
However, in case of complications, longer radiation time may be necessary- exposition time 
may rises above 5 rads. Because of lack of unequivocal directions, in this situation, the 
pregnancy termination could be imperative.  
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To the maximum security, usage of leaden protection for stomach, pelvis and lumbo-sacral 
region is recommended. 
According to data from literature, 55-89% women undergoing coronary angiography have 
received stents. During pregnancy we don’t possess certain data relevant to safety usage 
drug eluting stents, the bare metal stents in this situation are rather recommended.  
The great doubts are connected with coronary angioplasty during coronary artery dissection 
as a cause of acute coronary syndrome. According to European- American Guidelinesses 
from 2003 year, PCI is recommended in this situation. Nonetheless, numerous reports 
demonstrate that in case of stable patient state, the conservative treatment is also effective 
and in postpartum period the idiopathic healing is noticed.  
On the other hand, Roth indicate that during coronary angiography the risk of iatrogenic 
coronary artery dissection is increased, that’s why particular caution in qualification for 
invasive procedures in this period should be recommended.   
The reports concern of possible complications of invasive treatment during pregnancy are 
very rare. The single cases of contrapulsation aortic balloon usage during complications of 
extensive anterior wall myocardial infarction were described.  
Similarly, our knowledge about remote results of acute coronary syndromes invasive 
treatment in pregnant women is poor, but at present, this is a method from choice. 
Coronary artery bypass grafting (CABG) is the procedure performed extremely rarely 
during pregnancy. 
According to James’s et al. analysis, CABG was done in 51 pregnancy women (6% analyzed 
group), but  pregnancy period and results of the treatment data weren’t released.   
Another analysis by Roth and Elkayam 5 women underwent CABG during antepartum 
period. One of them died after 3 months and after delivery ( healthy child was born), in the 
second pregnant the fetal death in utero  came up. 
The most often direction of CABG is ineffectiveness or complications after PCI. During 
surgery the fetal monitoring is necessary, because hypothermia and extracorporeal 
circulation can cause fetal arrhythmias.  
The single reports about CABG in women during pregnancy suggest, that these procedures 
are connected with high risk for mother and child. 
4. The valuation of coronary arteries in menopausal women treated for acute 
coronary syndromes 
4.1 Impact of pathophysiological transformations during menopause on coronary risk 
Menopause is considered as a single, strong coronary risk factor. In this period in woman 
organism multidirectional changes are achieved. These transformations concern of lipid 
profile (increase of LDL, TGL, apolipoprotein B, apolipoprotein (a) level; decrease HDL and 
apolipoprotein AI level), coagulation factors production (significant  increase of fibrinogen 
level, increase of factor VII, antithrombin III and inhibitor tissue activator of plasminogen 
(PAI-1) activity), insulinoresistance’s  and abdomen’s obesity development. 
Disadvantageous is also impact of menopause for endothelium function.  
Though the current understanding of the role of menopause in cardiovascular diseases 
(CVD) is controversial, studies suggest that menopause does not exacerbate CVD 
independent of aging, and hormone replacement therapy is not effective for secondary 
prevention of CVD. 
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According to long-term 16 years observation over 11 thousands Italian population, 
menopause wasn’t found an independent cardiovascular risk factor.  
Despite above divergences, there is a fact, that cardiovascular women morbidity 
significantly rises during menopausal period.  
Inhibition of estradiol distribution during menopause constitutes of biological challenge for 
woman organism, especially for women aggravated other circulatory risk factors. The next 
years after menopause, on account of lack of estrogen coordinated in numerous metabolic 
transformations, are characterized intensification of existing diseases and another exposure. 
We can suspect that required of adaptation a new metabolic balance causes worse process 
and prognosis in menopausal women with coronary artery diseases.  
Presently, more often the differences in artery stiffness in female and male are emphasized. 
The genders differ in large artery biomechanical properties throughout the lifespan with 
females displaying higher stiffness than males during the prepubertal years and a dramatic 
increase after menopause. Males on the other hand experience an increase in arterial stiffness 
postpuberty and a linear increase thereafter, suggesting that females have intrinsically stiffer 
large arteries than males, but that such effects are mitigated by sex steroids during the 
reproductive years. These factors may contribute in part to the observed gender differences in 
the pathophysiology and clinical manifestations of cardiovascular disease. 
On the other hands, hormonal replacement therapy (HRT) usage to decreased of circulatory 
diseases risk in menopausal women is presently not recommended.  
4.2 Influence of hormonal replacement therapy on coronary artery state 
Reports relevant HRT are controversial. Until 1988 year, the knowledge about benefit effects 
of hormonal replacement therapy was based on only retrospective studies. Metaanalyses 
demonstrated 30-40% decreased of coronary disease’s risk mostly in women received 
conjugationed estrogens (less often together with progestagenes) and particularly good 
effects was observed in women with earlier recognized coronary disease.  
In 1998 year, the results of the first randomize, multicenter study- HERS were published. In 
this study the HRT effect in secondary prevention was assessed. In years 2002 and 2004 the 
next study results were presented- WHI I and WHI II- evaluated HRT implementation in 
primary prevention. In these studies the unambiguous evidences affirmed HRT benefits in 
circulatory diseases were expected. Adverse results were a big shock. The more amount of 
cardiovascular events in the first year of therapy, more numerous thromboembolic events 
and more often breast cancer were documented.  
From this time, the American Heart Association and European Cardiac Society 
recommended not initiating and no continuing hormonal replacement therapy in circulatory 
system diseases prevention. Repeated analysis of mentioned above studies demonstrated, 
that the important point is the period of HRT inclusion. It is suspected that earlier usage of 
HRT, in the beginning of menopause is probably more favourable than in later years. This 
effect is connected with HRT impact for not yet damaged endothelium.  
The therapy inception in the later years can favour of impairment’s of coagulation and 
inflammation mechanisms and in consequence’s  can be responsible for thromboembolic 
complications and unstability of atherosclerotic plaque.  
The greatest thromboembolic disorders risk was indicated in the first year of HRT therapy, 
particularly during oral treatment, because of first liver passage effect, which caused 
thrombotic processes stimulation. Transdermal estrogenes, deprived of first passage effect, 
don’t affect also for increased of CRP, fibrinogen and prothrombin level. 
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The results of Danish observation study (700 thousands healthy women) affirmed the 
beneficial effect of transdermal estrogens for cardiovasculatory system with myocardial 
infarction reduction and without the increased thromboembolic risk. 
Despite of optimistic reports, currently still doesn’t exist evidence that hormonal replacement 
therapy improve of survival and doesn’t indicate of side effects. Therefore, HRT indications 
still contain only clinical menopausal symptoms, not cardiovascular prevention. 
4.3 Coronary artery changes in menopausal women treated from acute coronary 
syndromes 
To this time, there are very little studies estimated the specific coronary angiography 
changes in menopausal women. One of sparse comparative analysis concerned assessment 
of these changes in pre- and postmenopausal women demonstrated more frequent 
involvement of triple vessels in postmenopausal CAD patients (33.8% vs 20.4%, p=0), and 
single vessel in premenopausal (43,2 % vs 26,9%, p=0) which indicated more serious CAD in 
postmenopausal patients. There was no significant difference in left main and double 
vessels involvement in the two groups.  
In postmenopausal group more lesion of middle left anterior descending (LAD), left 
circumflex artery (LCX) and right coronary artery (RCA) were found (all p value <0.05) 
compared to  much more severe lesions (≥90%) at left main (2.9% vs 1.1%, p=0.048) and 
proximal LAD (28.2% vs 16.6%, p=0) in the premenopausal CAD group.  
As for lesion length, there were more local lesions at the posterior descending artery (PDA) 
(6.4% vs 2.5%, P=0.014), diffuse lesion at diagonal 1 (7.1% vs 3.6% P=0.036), middle and 
distal RCA (13.5% vs 8.6%, P=0.033; 5.8% vs 2.1%, P=0.014) in the postmenopausal CAD 
group. But tubular lesion seemed to be located more at middle and distal LAD (19.6% vs 
9.0%, P=0; 12.1% vs 7.9%, P=0.036) in the premenopausal CAD group.  
Other items with regard to lesion length were comparable without a significant difference 
between the two groups.  
Probably, above observation confirm the different dynamism of atherosclerotic processes, 
connected with hormonal state. Additionally in mentioned study, in both of groups: pre- 
and postmenopausal women, the significant more often prevalence of prior myocardial 
infarction, hypertension, diabetes mellitus and dyslipidemia in CAD women compared to 
non CAD patients was documented. Furthermore, the frequency of coronary risk factors 
was higher in CAD postmenopausal group compared to premenopausal CAD women. 
Then, the high number of coronary risk factors in women probably correlates with more 
often multivessel coronary atherosclerotic changes. 
5. Comparison of efficacy percutaneous coronary interventions and coronary 
artery bypass grafts in women and men during acute coronary syndromes 
5.1 Review of clinical studies assessed gender differences in coronary interventions 
during acute coronary syndromes NSTEMI and STEMI 
Percutaneous  Coronary  Intervention (PCI) is the preferred technique for the treatment of 
acute coronary syndrome with or without ST-segment elevation according to the 
Guidelines. The available data concerned gender differences in qualification and PCI effects 
are still conflicted.  
Historically, the first PCI effects analysis coming from the end of XX century, in majority 
demonstrated a fewer qualification and worse prognosis in women treated by invasive 
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strategy. This effect was visible in all acute coronary syndromes types: ACS STEMI, 
NSTEMI and unstable angina.  
In FRISC II study, women PCI benefits weren’t indicated in comparison to conservative ACS 
NSTEMI treatment, whereas the definitely better PCI results in men were observed.  
In spite of more optimistic results of TACTICS TIMI 18 study, in which the benefits from 
invasive therapy with widely stents and inhibitor GP IIb/IIIa usage were evident also in 
women, in the next study RITA 3, the positive effects of early invasive strategy during 
NSTEMI indicated the strongly advantage in male compared to female.  
The reports concerned ACS STEMI were similar - there were documented an improvement 
of myocardial infarction therapy results in women, but, beside of better and better PCI 
techniques usage, greater PCI effects in men were demonstrated.  
In Stent PAMI study the ACS STEMI female mortality after six month observation was 
significantly higher than in male.  
The later study - CADILLAC also indicated higher STEMI population women after 30 days 
and 1 year, independent of kind of interventional technique’s.   
These worse results of procedures in women were tried to assign of major risk factors 
account (the more often prevalence of hypertension, diabetes and hiperlipidemia in female 
were confirmed in above studies), however in multivariable analysis the female sex was 
independent predictors of one - year more frequency of adverse events and mortality. 
The causes of this phenomenon aren’t still explained. Responsible could be the ACS clinical 
factors: delayed in disease’s onset detection, older age, hormonal factors and comorbidities 
(hypertension, diabetes mellitus)- more often found in women. Nonetheless, gender 
differences in efectivenesses of coronary interventions were visible despite of  allowing in 
studies and registries mentioned above factors.  
The impact of specific coronary angiography changes in women to coronary interventions 
results are also often named as a cause of worse effect of therapy. Especially, smaller coronary 
artery size can be the reason of more often dissection or vascular perforation after PCI.  
Based on reports from 1990 year, the frequency of vascular complications in women 
underwent of coronary interventions were about 3 fold higher than in men. This effect  is 
assigned to difficulties in tailoring catheters size’s to generally lower coronary arteries 
caliber in female.  
Other authors suggested that the higher mortality seen in women after an AMI might be 
explained by less aggressive treatment, and if women had access to the same quality of care 
as men, their survival would be the same. 
5.2 Current effects of coronary interventions in women 
Current studies evaluated of differences between female and male PCI effectiveness are still 
controversial.  
The analysis of the great PCI Registry (over 22 thousands procedures; 31,8%  women) 
showed, that compared with men, women were older, had a higher prevalence of 
comorbidities, and had a significantly higher frequency of adverse outcomes after PCI. After 
adjustment for baseline demographics, comorbidities, clinical presentation, and lesion 
characteristics, female gender was associated with an increased risk of in-hospital death, 
vascular complication, blood transfusion, stroke, and major adverse cardiac events (MACE).  
The relationship between female gender and increased risk of death and MACE was no 
longer present after further adjustment for kidney function and low body surface area. 
www.intechopen.com
 Acute Coronary Syndromes in Women - Gender Specific Changes in Coronarography 
 
91 
Authors concluded that differences in mortality rates between men and women no longer 
exist after PCI.  
This study included different clinical presentations of coronary artery disease with a mixed 
of ST- segment elevation myocardial infarction, non ST-segment elevation myocardial 
infarction (NSTEMI), unstable and stable angina, a heterogeneity which could minimize a 
difference to some extent.  
Current analysis of Polish ACS Registry, assessed population of 26,035 patients with ACS 
STEMI (34,5% women) was evidently demonstrated higher in-hospital (15% vs 9%, p<0,001) 
and one-year (22% vs 14,1%, p<0,001) women mortality. Coronary angiography was carried 
out significantly less often in female (47,8% vs 57,4% , p<0,001).  In women receiving 
interventional treatment, primary angioplasty was performed significantly less often within 
12 hours from symptom onset (35,8% vs 44,0%, p<0,001). The pharmacological treatment 
was less aggressive in women: GPIIb/IIIa inhibitor was administered in 12,2 % women vs  
16,8 % men (p<0,001). Foregoing results were assigned the worse ACS clinical female 
presentation. 
According to the Switzerland Registry included also over 20 thousands population 
hospitalized from ACS in 1997-2006 years (28% women) female gender was an independent 
factor for undergoing PCI less frequently. Although performed less often than in men, 
women benefited similarly from PCI and it was associated with lower in‐hospital mortality, 
whether or not ACS was associated with ST‐segment elevation. 
Very interesting information comes from currently conducted observations concerned 
evolution of PCI effects in female and male in connection with improvement of PCI 
techniques.  
According to retrospective analysis compared by gender two PCI populations: one of them 
consisted of patients underwent PCI between 1979-1995 (28% female), the second- between 
1996-2004 (31 female), PCI was successful in 89% of women and 90% of men. In the recent 
group, 30-day mortality was significantly reduced compared with that in the early group in 
women (2.9% vs. 4.4%, p = 0.002) and men (2.2% vs. 2.8%, p = 0.04). However, long-term 
survival was similar between the early and recent groups among both men and women. 
After adjustment for risk factors, there was no difference between men and women from 
1994 onward for either 30-day or long-term outcomes. Traditionally, compared with men, 
women undergoing PCI were older and more likely to have diabetes mellitus, hypertension, 
or hypercholesterolemia. 
Authors suggested that the 30-day mortality after PCI in men and women has decreased in 
the past 25 years. After accounting for baseline risks, no differences in short-term or long-
term mortality were observed between men and women. 
The next problem is the prevalence of coronary interventions complications. According to 
majority observations  in women more often than in men the periprocedural arteries 
damages and bleeding complications were found. 
Argulian et al. analyzed process of 4768 percutaneous coronary interventions performed 
between 2001-2004. 
The baseline characteristics, periprocedural complications, angiographic success, procedural 
success, and major in-hospital complications (death, myocardial infarction, and emergency 
coronary artery bypass graft surgery) after PCI were compared between men and women. 
Women were more likely older, with a significantly greater prevalence of hypertension and 
diabetes mellitus compared with men. After adjusting for baseline characteristics and 
coronary artery size, the incidence of coronary vascular injury complications was higher in 
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women than in men, particularly in patients <or=55 years (odds ratio [OR] 2.74, 95% 
confidence interval [CI] 1.49 to 5.04).  
The difference was less when comparing women and men >55 years (OR 1.32, 95% CI 0.87 
to 1.99, p = 0.047 for gender-age interaction).  
The bleeding complications were also more often demonstrated in women than in men 
(<or=55 years OR 5.39, 95% CI 2.26 to 12.8, >55 years OR 2.55, 95% CI 1.68 to 3.87, p = 0.121 
for gender-age interaction).  
No significant gender differences were present in a combined end point of death, 
myocardial infarction, and emergency coronary artery bypass graft surgery.  
Authors suggest, that among patients who have undergone PCI, women, particularly 
younger women, are more likely than men to experience coronary vascular injury and 
bleeding complications unaccounted for by coronary artery size and other patient 
characteristics. No differences were found in major in-hospital complications by gender. 
The next analysis of Northern New England PCI Registry (13563 women underwent  PCI in 
years 2002-07; 6,4% STEMI, 10,4% NSTEMI, 40,1 % unstable angina) demonstrated 
significantly improved rates of bleeding or vascular complications (VC) in women 
undergoing PCI during the past 6 years. The incidence of bleeding/VC decreased >50% in 
both men and women during the study period. Although these results are encouraging, this 
study demonstrates that women continue to be more than twice as likely as men to have 
significant bleeding/VC after PCI.  
Authors conclude that the persistence of the gender gap may suggest a role of inherent 
biological or anatomical differences between women and men, which have yet to be identified.  
The next retrospective analysis of current PCI Registry (8 thousands ACS STEMI 
population; 29% women) confirm that female sex was associated with a higher unadjusted 
in-hospital mortality (6.02% vs 3.45%, odds ratio [OR] 1.79, 95% CI 1.45-2. P < .0001) and 
higher risk of contrast-induced nephropathy (OR 1.75, P < .0001), vascular complications 
(OR 2.13, P < .0001), and postprocedure transfusion (OR 2.84, P < .0001). The gap in sex-
specific mortality narrowed over time. In a propensity-matched analysis, female sex was 
associated with a higher rate of transfusion (OR 1.88, 95% CI 1.57-2.24, P < .0001) and 
vascular complications (OR 1.65, 95% CI 1.26-2.14, P < .0002); but there was no difference in 
mortality (OR 1.30, 95% CI 0.98-1.72, P = .07).  
Authors suggest that these differences are explained by older age and worse baseline 
comorbidities among women. 
Lower observational studies increasingly suggest evanescence of gender differences among 
patients undergoing primary PCI during ACS.  These researches suspects that improvement 
of coronary intervention effectiveness’s is connected with usage of more intensive 
pharmacotherapy.  
The prospective analysis of 297 consecutive patients presenting with STEMI (27,6% women) 
treated by PCI with additional bare metal stent implantation and a GP IIb/IIIa inhibitor 
demonstrated that the incidence of major adverse cardiac events (MACE, defined as death, 
re-myocardial infarction, target lesion revascularization and coronary artery bypass graft) 
during long-term follow-up was similar in women and men (20% vs 26%, p = 0.29). In this 
study, female gender did not emerge as an independent predictor for MACE, but women 
presenting with STEMI had a higher cardiovascular risk profile; this emphasizes the need 
for a more extensive therapeutic strategy. Authors conclude that combination therapy with 
primary PCI and GP IIb/IIIa inhibitors might mitigate gender-related differences in clinical 
outcomes.  
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Above mentioned study results are affirmed by another observational reports.  
The retrospective analysis of 468 consecutive patients underwent PCI for ACS (29.3% 
female) demonstrated no significant gender differences in the short-term adverse event rate 
at 30 days despite of several important differences between female and male patients. 
Authors emphasizes women older age, smaller size of stent and first of all noticed that 
female patients were less likely to be treated with optimal medical therapy, with lesser use 
of glycoprotein IIb/IIIa inhibitors and beta-blockers.  
Therefore, we can suspect that further improvement of PCI technique and usage of 
respectively aggressive pharmacotherapy in women treated from acute coronary syndromes 
perhaps completely eliminate ACS gender gap.  
5.3 Evaluation of coronary artery bypass grafting effects in female compared to male 
The  surgical treatment effects of acute coronary syndromes in women are still differently 
assessed.  
In the previous years, when the coronary artery bypass grafting (CABG) was only one 
possibility of invasive strategy of advanced coronary artery diseases therapy, the 
Cardiosurgical Centers demonstrated increased mortality women underwent CABG.  
Despite the lapse of the time, these observations are affirmed through the successive clinical 
reports.  
There are the differences between studies results, because women constitute the lower 
group of patients undergoing CABG (20-30%). According to the great database of Society of 
Thoracic Surgeons (STS Database) - CABG was performed in 28% female patients 
hospitalized in years 1994-1996.  
Currently studies assessed prognosis in women and men after CABG still demonstrate 
conflicted results.  
The analysis over 70 thousands population of patients undergoing CABG in years 2003-2005 
reaffirmed a significant effect modification by gender in 39 hospitals; the adjusted odds 
ratios showed significant increased risk for females.  Authors suggest that the highest in-
hospital mortality of females is frequently explained by gender physiological differences 
related to technical issues in surgery.  
The smaller size of coronary arteries in women as compared with men has been often 
indicated as potentially increasing periprocedure and postprocedure complications in 
women.  Actually, the influence of vessel size on gender differential mortality after CABG 
surgery remains controversial. Two studies used the body size as an indicator of vessel size. 
One found that gender differential mortality persists after adjustment for measures of body 
size, while another study showed that, both in men and women small body size does not 
increase the risk of operative mortality. 
The next current analysis of 3441 patients (21,3% women) undergoing CABG between 2004-
2008 years showed significantly higher 30-days (5,2% vs 2,5%, p=0,01) and one year (8,7% vs 
4,8%, p=0,0008) women mortality. Moreover, these differences decline in patients operated 
using off-pump coronary artery bypass (OPCAB) technique. Authors suggest that female 
gender is a strong independent predictor and risk factor of increased postoperative 
mortality rates when extracorporeal circulation is used. OPCAB significantly reduces early 
and midterm postoperative mortality in women and may therefore be proposed as the 
preferred revascularization technique among female patients.  
In the literature we can meet also observation indicated lack of significant  differences 
between female and male prognosis after CABG, independent of surgical technique.  
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The analysis of group 954 patients undergoing CABG  (19,7% women) in 2004-2009 years 
demonstrated no gender differences in the clinical outcomes after surgery (only the 
cerebrovascular event rate was higher in females compared with that in males (4.3% vs 
1.6%; P=0.0432).  
In spite of conflicted reports concerned PCI and CABG effects in women, admittedly that 
review of currently literature demonstrates absolute benefits of reperfusion therapy of acute 
coronary syndromes in female and male. Majority of above analyzed  studies confirms 
baseline worse clinical ACS women presence, particularly older age, major coronary risk 
factors number  and more often occurrence of advanced heart failure, shock and cardiac arrest.  
Undoubtedly these factors, in significant way affects for worse early and distant prognosis. 
Certainly, relatively short time of ACS gender differences observation and generally lower 
women participation in clinical studies prevent unequivocal conclusions.  
The further studies are necessary with particular acknowledgement coronary anatomy and 
acute coronary syndromes pathophysiology in female and male.  
6. Analysis of selected cases of acute coronary syndromes in women 
In every day clinical practice we can see a lot of very interesting cases of specific acute 
coronary syndromes proceeding in female. According to earlier documentation, these 
contraries of ACS process are the most often presented during one of two particular women 
life periods: pregnancy and menopause.   
6.1 Acute myocardial infarction in a 29-year-old woman during postpartum period - 
specific coronary changes 
The case of acute coronary syndrome STEMI in 29-years old woman in postpartum period 
illustrate of atypical ACS pathophysiology.  
29- years old woman, three months after natural delivery was admitted to Cardiology Ward 
due to two- hours strong retrosternal pain. Heretofore patient was healthy, periodically 
complained for migraine and didn’t indicate any coronary risk factors. During pregnancy 
she received hormonal therapy- luteine. Physical examination didn’t demonstrate any 
abnormalities. In ECG- ST elevation in II, III, aVF, V5-V6 leads was revealed. Fig.1. 
Biochemical testes demonstrated significantly increased of TnT’s level (1,42 ng/ml). 
Echocardiography showed only descreet akinesis of apical segment lateral left ventricle wall 
with normal ejection fraction (EF- 65%). Coronary angiography revealed marginal branch 
aneurysm with prevalence of thrombus. Remaining coronary arteries were normal. Fig.2. 
On account of small size of marginal branch, patient was disqualified from coronary 
revascularization. The typical pharmacological ACS therapy was used: low molecular 
weight heparin, double antiplatelet treatment,  ACE-inhibitor, beta blocker and statin.  After 
these treatment, the patient clinical state was improved.  
Diagnostic process descoped congenital coagulation disorders as a cause of arterial 
thrombosis. Mutation prothrombin’s gene G 20210 was excluded. Antiphospholipid 
antibodies level was negative. Only fibrinogen level and fibrinogen degradation products 
level were significantly increased.  
During hospitalization any complications weren’t observed. In ECG the negative T waves in 
II, III, aVF leads occurred, without pathological Q waves.  
After ten days patient was discharged with further pharmacological treatment 
recommendation (ASA, Clopidogrel, beta blocker and statin). Only ACE-I was interrupted 
because of hypotension.  
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Fig. 1. ECG on admission. The description in the text. 
 
 
Fig. 2. Aneurysm with thrombus in marginal branch 
One year later, after ceasing of Clopidogrel therapy, woman was again admitted to 
Cardiology Ward with the same complaints. In ECG the ST elevation in the same leads were 
observed, troponin T level was again increased (0,8 ng/ml). Coronary angiography image 
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was also similar. The decision about further pharmacological treatment (double antiplatelet 
therapy) was maked.  
During long-term, three years observation, patient is in good condition, but over the time 
takes medication: ASA,  Clopidogrel, beta blocker, statin. 
This case of myocardial infarction in postpartum women with aneurysm of coronary artery 
is an extremely rare and it is the real diagnostic and therapeutic challenge. Particularly, it is 
difficult to explain the coincidence’s between both effects and make a decision about 
prevented of recurrences.  
Probably, the base of acute coronary syndrome in this case wasn’t typical, atherosclerotic. 
Perhaps the coronary artery aneurysm was a congenital malformation and in this particular 
postpartum period was favoured to initiation of thrombotic process. It is commonly 
allowed, that aneurysm prevalence increases the thrombosis risk and that during pregnancy 
and postpartum period this risk is still higher. It is a result of mentioned above coagulation 
system changes. Additionally, it is possible, that development of coronary artery dilatation 
could occur during pregnancy as an effect of progesterone influence’s on arterial wall. Then, 
the initial cause could be the arterial dissection.  
In conclusion, this case show very complicated pathogenesis of acute coronary syndromes 
during postpartum period. The problem is the great, because of lack of any experiences in 
the treatment. 
6.2 Analysis of two cases of women treated from acute coronary syndromes during 
menopausal period 
6.2.1 Case 1 
54-years old woman, treated from hypertension, with hypercholesterolemia in review, was 
admitted to Cardiology Department due to typical exercise angina pectoris. Patient has 
never smoked, BMI was correct-24 kg/m2. The last menstruation was two years ago, patient 
didn’t receive hormonal replacement therapy.   
Distance of angina accounted for 300 meters on plane terrain, the disorders had intensified 
during three months before hospitalization.  
On admission, patient was in good condition. Physical examination, ECG and biochemical 
parameters  were normal. Echocardiography showed hypokinesis of inferior and lateral left 
ventricular wall without worsening global ejection fraction- EF-60%.  
Exercise test (10,3 METs) revealed significant depression of ST segment in II, III, aVF, V4-V6 
leads  (Fig.3) with typical, retrosternal pain during exercise.  
Patient was qualified to further conservative treatment. The pharmacological therapy: ASA, 
beta blocker, ACE-I and statin was included (Clopidogrel was 7 years ago not yet commonly 
used in only conservative treatment). Patient was discharged in good condition. During 1- 
year observation, patient was stable.  
Therefore, she was admitted to hospital due to acute coronary syndrome NSTEMI (typical, 
rested retrosternal pain, ST depression, TnT level-0,19 ng/ml).  Coronary angiography again 
revealed noncritical, the same 40% LAD stenosis, without another atherosclerotic changes in 
remaining coronary arteries. This time, probe of conservative treatment was ineffective- 
patient complained for recurrence retrosternal pain. After a few days, the PCI of proximal 
LAD stenosis with metal stent implantation was performed. The pharmacological treatment 
was continued with Clopidogrel added after coronary intervention. 
In seven years observation patient is in good condition, without angina. 
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Fig. 3. Exercise test- visible ST segment depression in II, III, aVF, V4-V6 leads. 
Patient was qualified to coronary angiography due to unstable angina. Coronarography 
revealed noncritical 40% stenosis of proximal left anterior descending (LAD) artery segment. 
The remaining coronary arteries were normal. Fig.4. 
 
 
Fig. 4. Coronary angiogrogram. 40% LAD stenosis. 
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6.2.2 Case 2 
52-years old women with overweight (BMI-29 kg/m2), hypertension, smoking, 
hypercholesterolemia and TIA in review, was admitted to hospital due to unstable angina.  
The last menstruation was one year earlier, patient has never received hormonal 
replacement therapy.  
Three months ago patient was hospitalized due to ACS NSTEMI. Coronary angiography 
revealed non critical, 50% stenosis of right ventricular artery (RCA) without atherosclerotic 
changes in remaining arteries. Fig.5. 
 
 
Fig. 5. Coronary angiogram- 50% stenosis of RCA is visible 
After that, the typical pharmacoteraphy to stabilization atherosclerotic plaque was included 
(ASA, beta blocker, ACE-I, statin) and patient was discharged without complaints. 
Clopidogrel wasn’t popularly used to conservative ACS treatment 7 years ago 
After three months patient was again hospitalized due to recurrence retrosternal pain with 
radiation to the lower jaw, more often during the rest, in the night. On admission patient 
state was stable. Physical examination and TnT level were normal. In ECG the negative T 
vawe  in II, III, aVF leads was visible. Echocardiography showed hypokinesis of basal and 
middle segments of  left ventricular inferior wall’s and hypokinesis of interventricular 
septum with normal ejection fraction (EF-55%).  
Exercise test  (9,2 METs) didn’t revealed ST segment changes, it was finished after seven 
minutes due to patient fatigue. After pharmacological stabilization, patient was again 
discharged in good condition. 
One month later patient was again admitted to Cardiologic Intensive Care Unit due to 
inferior all acute coronary syndrome STEMI. In ECG- the typical ST elevation in II, III, aVF 
leads were revealed. Fig 6. 
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Fig. 6. ECG on admission- ST elevation in II, III, aVF leads. 
Coronary angiography reaffirmed only prevalence of 50% stenosis of middle RCA segment. 
This time, PCI- RCA with bare metal stent implantation was performed. Coronary 
intervention was complicated by RCA dissection with thrombus involved. After 
intracoronary GP IIb/IIIa served, TIMI III flow was attained. 
Further hospitalization was not complicated. Patient was again discharged in good 
condition. 
In 7- years observation patient state is stable. 
These cases of acute coronary syndromes in menopausal women are very specific. In both 
situations, despite typical symptoms, electrocardiographic and biochemical changes, 
coronary angiography didn’t revealed critical stenosis of infarction responsible artery. Only 
the recurrence of complaints caused the interventional treatment.  
It is important that ACS was presented during menopause in women with coronary artery 
risk factors. The essential is also fact the typical angina in both women, but noninvasive 
exercise test in second woman was doubted.   
Noninvasive diagnostic process in women with coronary disease is difficult. Anatomical 
conditions aggravate imagination diagnostic and small exercise tolerance is a barrier in 
exercises testing.   
Account of these facts, qualification to invasive diagnosis and treatment is more difficult 
than in men. Additionally, the coronary angiography changes are often nonspecific.  
There are a lot of studies demonstrating that coronary angiograms in ACS women are often 
normal, or reveal noncritical stenosis. Presumably, the cause of acute coronary syndrome is  
mentioned above the plaque erosion with thrombus forming on undamaged artery wall. 
The another possibility is coronary artery spasm or dissection with idiophatic healing.  
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These effects occur exceptionally often in women during pregnancy and menopause in 
connection with hormonal changes in these periods. 
Treatment of these cases is very difficult and should be empirical. 
7. Conclusions 
Women cardiovascular diseases are currently even more problematic than earlier. Mostly, 
the present data indicate, that female cardiovascular morbidity still rises. This effect is 
connected with a lot of factors.  
Modern women have professional and housewife responsibilities, consume excess of fat and 
carbohydrates, smoke, do not exercise regularly and do not have enough time to rest. This 
situation leads to overweight, dyslipidemia, arterial hypertension, impaired glucose 
tolerance and diabetes.  
Women do not often participate in preventive studies and, probably still undergo less 
intensive and invasive evaluation and treatment for chest pain when compared to men.  
However, currently studies are more optimistic. Much of them show that in this era the 
gender gap will evanescence. 
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